Skip to main content
Premium Trial:

Request an Annual Quote

Surgeon General Out

Vivek Murthy has been dismissed as US surgeon general, the Associated Press reports.

Murthy was appointed to the position by President Barack Obama and was asked to stay on by the Trump administration, but Murthy was asked to resign last week after "assisting in a smooth transition," according to a Department of Health and Human Service spokesperson. A White House statement adds that HHS Secretary Tom Price "thanks him for his dedicated service to the nation," according to Vox.

The New York Times indicates, though, that Murthy refused to step down and was fired. Vox adds that it took a year for Murthy to be confirmed as he supports gun-control measures and the Affordable Care Act, also known as Obamacare.

In a Facebook post, Murthy says he is "exceedingly proud of what our team and our officers have done to bring help and hope to people all across America."

"While I had hoped to do more to help our nation tackle its biggest health challenges, I will be forever grateful for the opportunity to have served," he adds.

Rear Admiral Sylvia Trent-Adams, a former nurse officer in the US Army who has a PhD from the University of Maryland and who was Murthy's deputy, is now serving as acting surgeon general, the AP adds. 

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.